Hiromi Kanno‐Okada
Papers
1
Total Citations
3
H-Index
1
About
Dr. Hiromi Kanno‐Okada is a distinguished surgical oncologist whose research centers on advanced minimally invasive approaches for gastric cancer, with a particular focus on Epstein-Barr virus-associated gastric cancer (EBVaGC). Her most cited work, "Robot-assisted laparoscopic total gastrectomy for Epstein–Barr virus-associated multiple gastric cancer" (2020), demonstrates her pioneering contributions to robotic surgery for complex, multifocal malignancies. In this landmark study, she successfully performed a robot-assisted total gastrectomy on a patient with four synchronized EBVaGC lesions, showcasing the precision and feasibility of robotic techniques in managing rare, multicentric gastric tumors. With 3 citations, this case report has provided critical insights into surgical decision-making for EBVaGC, a subtype known for its distinct molecular profile and tendency toward multiplicity. Dr. Kanno‐Okada’s work bridges the gap between viral oncology and surgical innovation, offering a tailored approach that improves outcomes for patients with this challenging disease. Her research continues to influence the integration of robotic platforms in gastric cancer surgery, emphasizing safety, oncologic efficacy, and the potential for personalized treatment strategies in rare cancer presentations.
Research Focus
Key Achievements
Top Papers
- 1